{"transactions":[{"id":1122394,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-06-04T21:08:28.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":103225,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":103225,"derivative":{"exercise_price":7.75,"exercise_date":"2025-06-03","expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":103225},"source":{"system":"sec-edgar","filing":"0000950170-25-081741","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000095017025081741/ownership.xml","form_type":"4"}},{"id":1216848,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note (convertible into Common Stock)","published_at":"2025-03-07T21:06:57.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":false,"shares":3442341,"price":5.81,"value":20000001.21,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Convertible Note had a stated maturity date of February 15, 2026. The Convertible Note, including any accrued but unpaid interest, was converted into shares of Common Stock on March 5, 2025 at a conversion price of $5.81 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Convertible Note had a stated maturity date of February 15, 2026. The Convertible Note, including any accrued but unpaid interest, was converted into shares of Common Stock on March 5, 2025 at a conversion price of $5.81 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":0,"derivative":{"exercise_price":5.81,"underlying":"Common Stock","underlying_shares":3442341},"source":{"system":"sec-edgar","filing":"0000950170-25-035494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000095017025035494/ownership.xml","form_type":"4"}},{"id":1216847,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T21:06:57.000Z","date":"2025-03-05","kind":"exercise","planned":false,"acquired":true,"shares":3500573,"price":5.81,"value":20338329.13,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":5416212,"source":{"system":"sec-edgar","filing":"0000950170-25-035494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000095017025035494/ownership.xml","form_type":"4"}},{"id":1433341,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"ten_percent_owner":true}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"ten_percent_owner":true}}],"security":"Convertible Note (convertible into Common Stock)","published_at":"2024-08-14T20:41:38.000Z","date":"2024-08-12","kind":"purchase","planned":false,"acquired":true,"shares":3442341,"price":5.81,"value":20000001.21,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 12, 2024, GKCC, LLC (the \"Purchaser\") purchased from the Issuer a convertible note with an aggregate principal amount of $20,000,000 (the \"Convertible Note\"). The Convertible Note is convertible into shares of common stock of the Issuer at a conversion price of $5.81 per share, subject to adjustment in certain circumstances. Therefore, the Convertible Note is initially convertible into approximately 3,442,341 shares of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Convertible Note will mature on February 15, 2026, unless earlier converted in accordance with the terms of the Convertible Note. Interest on the Convertible Note is payable in cash and will accrue and be payable quarterly on the principal amount equal to 3% per annum."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Convertible Note will mature on February 15, 2026, unless earlier converted in accordance with the terms of the Convertible Note. Interest on the Convertible Note is payable in cash and will accrue and be payable quarterly on the principal amount equal to 3% per annum."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of the Purchaser and may be deemed to beneficially own the shares held by the Purchaser."}],"balance_after":3442341,"derivative":{"exercise_price":5.81,"underlying":"Common Stock","underlying_shares":3442341},"source":{"system":"sec-edgar","filing":"0001140361-24-037346","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124037346/form4.xml","form_type":"4"}},{"id":1462090,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"ten_percent_owner":true}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"ten_percent_owner":true}}],"security":"Pre-Funded Warrants","published_at":"2024-07-02T20:30:42.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":1600000,"price":4.99,"value":7984000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants do not have an expiration date."}],"balance_after":1600000,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":1600000},"source":{"system":"sec-edgar","filing":"0001140361-24-032163","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124032163/form4.xml","form_type":"4"}},{"id":1462089,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"ten_percent_owner":true}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"ten_percent_owner":true}}],"security":"Common Warrants","published_at":"2024-07-02T20:30:42.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":1600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Common Warrants expire on July 1, 2029."}],"balance_after":1600000,"derivative":{"exercise_price":5,"underlying":"Common Stock","underlying_shares":1600000},"source":{"system":"sec-edgar","filing":"0001140361-24-032163","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000114036124032163/form4.xml","form_type":"4"}},{"id":1565709,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Common Stock Purchase Warrant","published_at":"2024-03-20T20:28:11.000Z","date":"2024-03-19","kind":"purchase","planned":false,"acquired":true,"shares":1032702,"price":5.81,"value":5999998.62,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Pre-Funded Warrant will be exercisable by GKCC, LLC at any time on or after March 19, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder approval is obtained."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants do not have an expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":1032702,"derivative":{"exercise_price":0.01,"underlying":"Common Stock","underlying_shares":1032702},"source":{"system":"sec-edgar","filing":"0000950170-24-034198","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000095017024034198/ownership.xml","form_type":"4"}},{"id":1699971,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":318,"kind":"person","name":"Chudnovsky Yekaterina","position":1,"cik":"0001979324","reported_name":"Chudnovsky Yekaterina","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":78875,"kind":"organization","name":"GKCC, LLC","position":2,"cik":"0001977769","reported_name":"GKCC, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-26T21:29:30.000Z","date":"2023-12-22","kind":"purchase","planned":false,"acquired":true,"shares":1213000,"price":5.81,"value":7047530.0,"ownership":{"direct":false,"nature":"Held by GKCC, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC."}],"balance_after":1915639,"source":{"system":"sec-edgar","filing":"0001209191-23-059683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000120919123059683/doc4.xml","form_type":"4"}}]}